<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>A.S. Lifesciences</provider_name><provider_url>https://medniti.com/aslife</provider_url><author_name>admin</author_name><author_url>https://medniti.com/aslife/author/mac/</author_url><title>Rifaximine Tablet Manufacturer - A.S. Lifesciences</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="FNqrEGra0j"&gt;&lt;a href="https://medniti.com/aslife/rifaximine-tablet-manufacturer/"&gt;Rifaximine Tablet Manufacturer&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://medniti.com/aslife/rifaximine-tablet-manufacturer/embed/#?secret=FNqrEGra0j" width="600" height="338" title="&#x201C;Rifaximine Tablet Manufacturer&#x201D; &#x2014; A.S. Lifesciences" data-secret="FNqrEGra0j" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://medniti.com/aslife/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><description>Rifaximin is a tablet manufactured by A.S. Lifesciences for the treatment of hepatic encephalopathy in adults. It is used to reduce and control episodes of liver disease caused by toxins produced by bacteria in the intestines. This toxin can cause symptoms such as confusion, disorientation, fatigue and coma in the brain due to its accumulation over time. Rifaximin tablets are also used to treat irritable bowel syndrome and other conditions where reducing bacterial toxins might be beneficial. A doctor must determine if this medication is appropriate for a patient's condition before prescribing it.</description><thumbnail_url>https://medniti.com/aslife/wp-content/uploads/2023/02/Rifaximine-Tablet-Manufacturer.png</thumbnail_url></oembed>
